Search for Clinical Trial Results
Philadelphia Chromosome - 26 Studies Found
Status | Study |
Completed |
Study Name: Rollover Study of BMS-354825 in Patients With CML and Ph+ALL Condition:
|
Withdrawn |
Study Name: Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL Condition:
Date: 2006-07-06 Interventions: Drug: Dasatinib |
Withdrawn |
Study Name: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia Condition:
Interventions: |
Completed |
Study Name: Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia Condition: Philadelphia Chromosome Positive Acute Lymphocytic Leukemia Date: 2005-09-09 Interventions: Drug: Imatinib Mesylate Other Names:
|
Completed |
Study Name: A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Condition: Myelogenous Leukemia, Chronic Date: 2012-01-01 Interventions:
|
RECRUITING |
Study Name: Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia Condition: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Date: 2024-05-19 Interventions: Ancillary studies |